Exit this survey >>

This independent study by PatientView looks at the corporate reputation of 46 pharmaceutical companies in 2017.
 
Thank you for participating.

Please note that, when you finish this survey, your responses will not be registered until you click the “Done >>” button at the bottom of this webpage.
 
Just a note about the names of some of the companies:
Actelion Pharmaceuticals Ltd was bought by Johnson & Johnson in June 2017 (and is now part of Janssen).
Baxalta was bought by Shire in 2017.
GSK can also be called GlaxoSmithKline.
Janssen is part of the Johnson & Johnson family of companies.
Merck & Co. is the US company (known as MSD outside Canada and the USA).
Merck KGaA, Darmstadt, Germany is the German company (known as EMD Serono in the United States and Canada).
Novartis includes Sandoz.
Pfizer includes Hospira.
Roche is known as Genentech in the US, and as Chugai in Japan.
Teva is known as Pliva in South-eastern Europe, and as Silom in Thailand.

Question Title

Image

Question Title

* FIVE PROFILING QUESTIONS

These profiling questions will help us understand THE TYPES of organisations answering the survey, and allow us to make more sense of the results.


a.) What is your organisation's MAIN SPECIALTY?

Please select only ONE option (the most important).

Question Title

Image

Question Title

* b.) In which COUNTRY is your organisation BASED or headquartered?

(If you are a patient group with an international remit, please respond on behalf of the country in which you, as a respondent, reside.)

Please select your country from the menu below.

Question Title

Image

Question Title

* c.) What is the GEOGRAPHICAL REMIT of your organisation?

Question Title

Image

Question Title

* d.) Below is a list of 46 top pharma companies worldwide.
Can you indicate which companies are FAMILIAR TO YOUR ORGANISATION, and with which companies has YOUR ORGANISATION WORKED/PARTNERED?

  We are FAMILIAR with this company. We have WORKED or PARTNERED with this company.
AbbVie.
Acorda Therapeutics.
Allergan.
Almirall.
Amgen.
Astellas Pharma.
AstraZeneca.
Bayer.
Bial.
Biogen.
Boehringer Ingelheim.
Bristol-Myers Squibb.
Celgene.
Chiesi Farmaceutici.
CSL Behring.
Daiichi Sankyo.
Eisai.
Eli Lilly (Lilly).
Ferring.
Gedeon Richter.
Gilead Sciences.
Grifols.
Grünenthal.
GSK.
Ipsen.
Janssen.
LEO Pharma.
Lundbeck.
Menarini.
Merck & Co / MSD.
Merck KGaA / EMD Group.
Novartis.
Novo Nordisk.
Octapharma.
Otsuka.
Pierre Fabre Laboratories.
Pfizer.
Roche (Genentech in the US).
Sanofi.
Servier.
Shire.
Takeda.
Teva.
UCB.
Vertex Pharmaceuticals.
ViiV Healthcare.
None of the above.
I do not know.

Question Title

Image

Question Title

* e.) If your organisation works/partners with pharma companies:
What are the MAIN TYPES of WORKING/PARTNERING RELATIONSHIPS your organisation has with pharma companies?

Question Title

Image
Questions on Corporate Reputation 

This survey is on the subject of the corporate reputation of the pharmaceutical industry—and individual pharmaceutical companies—in 2017.

For the purposes of this survey, please regard the phrase 'corporate reputation' to be defined as:
THE EXTENT TO WHICH PHARMACEUTICAL COMPANIES ARE MEETING THE EXPECTATIONS OF PATIENTS AND PATIENT GROUPS.

Question Title

Image

Question Title

* FIRSTLY, TWO QUESTIONS ABOUT THE CORPORATE REPUTATION OF
THE PHARMA INDUSTRY AS A WHOLE



Question 1 of 12.
How do you think your organisation’s members (or the people you represent) would RATE THE CORPORATE REPUTATION of the following healthcare SECTORS in 2017?

  Excellent. Good. Fair. Poor. I do not know.
Biotechnology companies.
Generic drug manufacturers.
Health insurers (for-profit).
Health insurers (not-for-profit).
Medical-device companies.
Pharmaceutical companies (multinational).
Pharmacy Benefit Managers (PBMs)—if relevant in your country.
Private-sector healthcare services.
Retail pharmacists.

Question Title

Image

Question Title

* Question 2 of 12.
How GOOD or BAD do you think the pharmaceutical industry as a whole has been in 2017 at CARRYING OUT THE FOLLOWING ACTIVITIES (all of which influence the industry's corporate standing with patients and patient groups)?

  Excellent. Good. Fair. Poor. I do not know.
Having a patient-centred strategy.
Providing high-quality information for patients.
Ensuring patient safety.
Being innovative.
Making high-quality, useful products.
Being transparent about company pricing policies.
Being transparent by sharing clinical data.
Being transparent by disclosing funding to stakeholders (such as doctors).
Acting with integrity.
Working in partnership with patient groups.
Providing patients with more services than just the provision of medicines.
Engaging patients/patient groups in product research.
Engaging patients/patient groups in product development (including clinical trials).

Question Title

Image
THE SURVEY’S FINAL NINE QUESTIONS ARE ON THE CORPORATE REPUTATION OF INDIVIDUAL PHARMA COMPANIES


For the companies listed in questions 3 to 12 inclusive:

Please ignore any companies with which you are unfamiliar.

Note that Merck & Co. is the US company (known as MSD outside Canada and the USA) ...and...
Merck KGaA is the German company (also known as EMD Group).

Question Title

Image

Question Title

* Question 3 of 12.
If you were asked to make a definite choice:
Which THREE companies were BEST in 2017 at having an EFFECTIVE PATIENT-CENTRED STRATEGY?

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 4 of 12.
If you were asked to make a definite choice:
Which THREE companies were BEST in 2017 at providing HIGH-QUALITY INFORMATION FOR PATIENTS?

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 5 of 12.
If you were asked to make a definite choice:
Which THREE companies were BEST in 2017 at ensuring PATIENT SAFETY?

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 6 of 12.
If you were asked to make a definite choice:
Which THREE companies were BEST in 2017 at supplying HIGH-QUALITY, USEFUL PRODUCTS?

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 7 of 12.
If you were asked to make a definite choice:
Which THREE companies have the BEST record in 2017 at being TRANSPARENT in the following subject areas?

(i.) BEST record at being TRANSPARENT in 2017 about the COMPANY'S PRICING POLICIES?
[This question is NEW for 2017]

Please tick/check no more than THREE.

Question Title

*
(ii.) BEST record at being TRANSPARENT in 2017 about SHARING THE RESULTS OF CLINICAL TRIALS?
[This question is NEW for 2017]

Please tick/check no more than THREE.

Question Title

*
(iii.) BEST record at being transparent in 2017 about the COMPANY'S FUNDING OF EXTERNAL STAKEHOLDERS (such as doctors and patient groups)?
[This question is NEW for 2017]

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 8 of 12.
If you were asked to make a definite choice:
Which THREE companies have the BEST record in 2017 for acting with INTEGRITY?

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 9 of 12.
If you were asked to make a definite choice:
Which THREE companies BEST WORKED IN PARTNERSHIP in 2017 WITH YOUR PATIENT GROUP (OR WITH THE PATIENTS WITH WHOM YOU ARE FAMILIAR)?

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 10 of 12.
[This question is NEW for 2017]
If you were asked to make a definite choice:
Which THREE companies BEST supported patients 'BEYOND THE PILL' in 2017?
(That is: understand the patient journey, and provide services beyond just the provision of medicine.)

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Question 11 of 12.
If you were asked to make a definite choice:
Which THREE companies were BEST in 2017 at ENGAGING PATIENTS in ...

(i.) Their company's PRODUCT RESEARCH?
[This question is new for 2017]

Please tick/check no more than THREE.

Question Title

*
(ii.) ENGAGING PATIENTS in their company's PRODUCT DEVELOPMENT (including clinical trials)?
[This question is NEW for 2017]

Please tick/check no more than THREE.

Question Title

Image

Question Title

* Finally, question 12 of 12.
[NEW for 2017]
If your organisation works/partners with one (or more) pharma companies:
How LIKELY would you be to RECOMMEND the company or companies THAT YOU WORK WITH TO ANOTHER PATIENT ORGANISATION?

[On a scale of 0 to 10:
10 = Would DEFINITELY recommend this company. And ...
0 = Would definitely NOT recommend this company.]

If you DO NOT work, or partner, with any pharma company: please skip this final question.

  SCORE
AbbVie.
Acorda.
Allergan.
Almirall.
Amgen.
Astellas.
AstraZeneca.
Bayer.
Bial.
Biogen.
Boehringer Ingelheim.
Bristol-Myers Squibb.
Celgene.
Chiesi.
CSL Behring.
Daiichi Sankyo.
Eisai.
Eli Lilly (Lilly).
Ferring.
Gedeon Richter.
Gilead.
Grifols.
Grünenthal.
GSK.
Ipsen.
Janssen.
LEO Pharma.
Lundbeck.
Menarini.
Merck & Co / MSD.
Merck KGaA / EMD Group.
Novartis.
Novo Nordisk.
Octapharma.
Otsuka.
Pierre Fabre.
Pfizer.
Roche (Genentech in the US).
Sanofi.
Servier.
Shire.
Takeda.
Teva.
UCB.
Vertex.
ViiV.

Question Title

Image

Question Title

* Thank you. Would you like any comments you might have made to be ATTRIBUTED in the published results of the study?

Question Title

* If "Yes", please note your organisation's NAME or WEB ADDRESS here.

Question Title

Image
As a patient-group representative responding to this study, you are entitled to receive a free copy of the 2017 survey’s worldwide results upon publication, if you wish.
To receive your free copy, please complete the five questions about your contact details, below.

Question Title

* a. What is your name?

Question Title

* b. If you haven’t mentioned it above, can you confirm the name of your organisation?

Question Title

* c. What is your title/position in the organisation?

Question Title

* d. To which email address should PatientView send the link to the report?

Question Title

* e. Lastly, are you happy for PatientView to include these contact details in our list of patient groups?

Question Title

Image
Thank you for expressing your opinions.

That concludes this November 2017 to February 2018 survey on patient groups’ opinions about the corporate reputation of the pharmaceutical industry in 2017.

After exiting this questionnaire, you will be taken to a page on the PatientView website that gives more information on when the results of this study will be published.

End of survey.

Please click "Done >>", below (otherwise your responses will not be saved).
( Privacy & Cookie Notice

T